Margaret Moline, PhD

Executive Director, Head of Orexin Platform Clinical Development Lemborexant and E2086
Eisai Inc.
Nutley, New Jersey

Presentation(s):

• Poster Number-53 - Response to Treatment with Lemborexant in Older Subjects with Insomnia Disorder and Comorbid Pain at Baseline

  Poster Abstracts